Patients' perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study.  Scott G, Turner S, Lowry N, Hodge A, Ashraf W, McClean K, Kelleher M, Mitcheson L, Marsden J.&n…

"Sign Me Up": a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic.  Darnton JB, Bhatraju EP, Beima-Sofie K, Michaels A, Hallgren KA, Soth S, Grekin P, Woolworth…

Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey.  Brothers S, Palayew A, Simon C, Coulter A, Strichartz K, Voyles N, Vincent L.  Harm Reduct J. 2023 Mar 9;20(1):31…

Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.  Abidogun TM, Cole TO, Massey E, Kleinman M, Greenblatt AD, Seitz-Brown CJ, Magidson JF, Belcher AM. …

Telehealth for management of chronic non-cancer pain and opioid use disorder in safety net primary care.  Cooke A, Castellanos S, Enriquez C, Olsen P, Miaskowski C, Kushel M, Knight KR.  BMC Health Serv Res. 2023 Apr 1;23(1):325. doi: 10…

Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.  Jones CM, Shoff C, Blanco C, Los…